Funding

Biocaptiva

United Kingdom · Biotech · Healthtech

Develops liquid biopsy technology for early cancer detection

Visit biocaptiva.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A£15.8MArchangels — Role not disclosedMaven Capital Partners — Role not disclosedOld College Capital — Role not disclosedScottish Enterprise — Role not disclosed

Investors

ArchangelsSeries AMaven Capital PartnersSeries AOld College CapitalSeries AScottish EnterpriseSeries A

Coverage

Mar 15, 2026Biocaptiva · Series A

Similar companies

Estuary BiotherapeuticsEstuary Biotherapeutics develops locally delivered gene therapies for patients with inherited polycystic kidney disease.$93M · Series A
Abby CareAbby Care trains and supports eligible family members as paid caregivers, combining nurse-led care management with software that documents care at home.$82M · Series C
OMass TherapeuticsOMass Therapeutics develops small-molecule medicines for endocrine and immune diseases using a platform that measures drug targets in their biological surroundings.$310M · Series C
Sourcesbiocaptiva.com ↗